Navigation Links
New vaccine for brain cancer

For 18 years, Keith Black, M.D., from Cedars-Sinai Medical Center in Los Angeles has been searching for an effective treatment for brain cancer. While his research moves forward, he’s helping patients live longer along the way.// Latest research involves an effective brain tumor vaccine.

Dr. Black says brain tumors try to hide proteins on the tumor cell surface that the immune system could use to recognize the tumor. By hiding these cells, brain tumors become difficult to eradicate. The first step of research strips these “hidden” proteins from tumor cells and then cultures them from a piece of a patient’s tumor that’s removed with surgery. Next, come dendritic cells. Dendritic cells make up a very small percentage of the white blood cells, but they are the most efficient cells for presenting foreign proteins to the immune system. After isolating the dendritic cells, researchers say, they essentially have developed a technique to put these proteins [that the tumor tries to “hide”] directly on these [dendritic cells] and allow these cells to present these back to the proteins to the immune system by giving these cells back under the skin just as a shot, like a vaccine.

Researchers say the killer immune cells then recognize it and divide into millions of powerful T-cells. Now, when they see the tumor with this protein on the surface, they will try to attack it and kill the tumor cell.

It sounds confusing, but it works. By giving this vaccine, patients are surviving longer. Early research suggests, when combined with chemotherapy, the vaccine increases the two-year survival of patients with grade IV glioblastomas -- the deadliest type of brain cancer -- from 5 percent to nearly 40 percent.

However specialist’s newest endeavor is to inject the vaccine directly into the tumor of patients whose cancer has recurred. In the first patient vaccinated this way, the tumor appears to be at least stabilizing. Ultimately, researchers say they hope that they will be able to eliminate the need for surgery altogether by combining this strategy with non-invasive strategies of destroying the tumor and ... just putting these cells right into the tumor to allow the tumor to be eradicated.

Another research found that age matters when predicting length of survival. Hence Younger patients with a grade IV tumor will do much better than a 70-year-old with a grade II tumor, so there’s something related to age that has a huge impact on the survival of these tumors.

Younger patients have more T-cells ... that can be called up to fight these tumors. That accounts for the entire age effect and the survival of these patients. We know that the immune system is really the reason why younger patients do much better with these aggressive tuors.
'"/>




Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: